It was wonderful getting our team together virtually for our holiday party last week. It was a day full of making cheeseboards & gingerbread houses, showing off our ugliest sweaters and even a workout! We look forward to being able to celebrate together in person again.

We’re ready to ring in the new year and take on 2021! We want to wish a Happy New Year to our amazing colleagues & families, as well as the patient and advocacy communities that inspire our work. #HappyNewYear2021

Our CMO Irina Antonijevic had the opportunity to chat with HDYO founder Matt Ellison about our efforts to develop a therapy designed to delay or prevent the onset and progression of #Huntingtonsdisease. Check out the full conversation here: bit.ly/2WqggOo

We are happy to participate in the upcoming @SoleburyTrout Winter Private Company Showcase. Triplet Founder, President & CEO Nessan Bermingham, Ph.D., will present on Friday, January 29 at 2pm ET. Register to view the presentation here: bit.ly/35Fwx7o

Leading up to #RareDiseaseDay our team recognized this important day in a recent meeting with special themed Zoom backgrounds.

We are proud to be a member of the newly launched Critical Path Institute (C-Path) Critical Path to Therapeutics for the Ataxias Consortium, a public-private partnership that seeks to optimize clinical trials for inherited ataxias. Learn more here: bit.ly/3ksEYZV

A big thank you to Erika Jefferson, president and founder of BWISE, for speaking with our team earlier this month and raising awareness of the leadership gap for black women in science. Learn more about BWISE here: bit.ly/37OQDNv

Today we recognize the community impacted by rare diseases which inspires our work toward developing new therapies. Learn more about #RareDiseaseDay here: bit.ly/2CDgc28

Today is International Women’s Day! Join us in celebrating the incredible accomplishments of women at Triplet and women around the world #IWD2021

We are looking for passionate people to join our diverse team of individuals who are motivated to transform treatment options for people living with repeat expansion disorders. Check out our current opportunities here: bit.ly/3qA0Fsj #biotechjobs

We are proud to be Gold sponsors of the @huntingtonsc 2021 Virtual National Conference where we will join in discussions and learn from researchers and leaders in the Huntington’s disease community. #HDCon21

Last week, we announced our CEO, president and founder Nessan Bermingham will present at Stifel’s 3rd Annual CNS Day fireside chat and the Guggenheim Healthcare Talks on April 1, 2021. More in our release here: bwnews.pr/39eVZ5h

Today is #WorldHealthDay which was established by the World Health Organization (WHO) almost 70 years ago. We recognize the achievements and hard work toward improving world health, and we are committed to being a part of the progress that is yet to come!

We are proud to see our CMO, Irina Antonijevic, M.D., Ph.D., elected as Industry Co-Director for Critical Path Institute (C-Path) Critical Path to Therapeutics for the Ataxias Consortium. We look forward to continued collaboration for this important initiative. More here: bit.ly/3mPvwku

Today at the CHDI HD Therapeutics Conference, we presented preclinical data for TTX-3360, an ASO delivered by ICV injection and which targets MSH3, a component of the DDR pathway. We also highlighted our new 1% equity pledge. Learn more here: bwnews.pr/3dUCXDS

May is Huntington's Disease Awareness Month, so #letstalkaboutHD. We are proud to be a part of the HD community and strive to prevent repeat expansion disorders like HD and ensure a future for our patients. Learn more from Ian Hammer here: hdsa.org

At Triplet we aim to develop therapies for manifest as well as premanifest HD. Our goal is to delay or prevent this devastating disease by targeting HD at its source. #letstalkaboutHD

“Time is precious, waste it wisely.” Jonathan has adopted this saying as his Mantra after recently participating in genetic testing that confirmed his #HuntingtonsDisease diagnosis. Learn more about his story here: bit.ly/3tndW8Y